In a study by Cheng et al. [74], TGF-β-induced EMT changes were demonstrated in serous borderline ovarian tumour (SBOT) cells, indicating that TGF-β-induced EMT is possibly involved in the progression from non-invasive SBOT to invasive low grade ovarian cancer (LGC) and that targeting the TGF-β signalling pathway could prevent the progression from borderline ovarian tumour to ovarian cancer. Here, TGFB1 is linked to ovarian cancer.